Amprius Technologies (NYSE:AMPX) Trading Up 3.3% – Still a Buy?

Shares of Amprius Technologies, Inc. (NYSE:AMPX) were up 3.3% during mid-day trading on Wednesday . The company traded as high as $19.40 and last traded at $18.60. Approximately 10,955,934 shares were traded during trading, an increase of 19% from the average daily volume of 9,229,597 shares. The stock had previously closed at $18.00.

Amprius Technologies News Summary

Here are the key news stories impacting Amprius Technologies this week:

• Positive Sentiment: Northland Securities raised Q1 EPS estimates for AMPX, improving near-term earnings visibility and giving bulls a fundamental reason to buy. Q1 EPS Estimates for AMPX Increased by Northland Securities
• Positive Sentiment: Needham & Company reaffirmed its Buy rating on AMPX (and other brokers have raised targets or reiterated buys), adding analyst-level validation that can attract institutional and retail inflows. Needham & Company LLC Reaffirms Buy Rating for Amprius Technologies (NYSE:AMPX)
• Neutral Sentiment: Coverage summarizing Northland’s forecast for AMPX Q4 earnings provides modeling context for investors but is informational until tied to company guidance or additional upgrades. What is Northland Securities’ Forecast for AMPX Q4 Earnings?
• Negative Sentiment: Director Steven Chu sold 155,565 shares on March 12 at an average price of $18.50 (~$2.88M), cutting his holdings by roughly 55% — a large insider sale that can be interpreted as a negative signal and may create short-term downward pressure. SEC Filing: Steven Chu Sale (3/12)
• Negative Sentiment: On March 10 the same director sold another 166,632 shares at an average of $17.92 (~$2.99M). The consecutive large sales amplify the negative signaling despite possible non-operational reasons (tax, diversification). SEC Filing: Steven Chu Sale (3/10)

Wall Street Analysts Forecast Growth

A number of brokerages have recently commented on AMPX. Cantor Fitzgerald raised their price target on Amprius Technologies from $16.00 to $20.00 and gave the company an “overweight” rating in a report on Friday, March 6th. William Blair reiterated an “outperform” rating on shares of Amprius Technologies in a research report on Friday, March 6th. Oppenheimer restated an “outperform” rating and set a $17.00 price target on shares of Amprius Technologies in a research report on Tuesday, December 23rd. Needham & Company LLC reaffirmed a “buy” rating and issued a $20.00 price target on shares of Amprius Technologies in a research note on Tuesday. Finally, Craig Hallum raised their price objective on shares of Amprius Technologies from $17.00 to $21.00 and gave the company a “buy” rating in a research note on Friday, March 6th. Eight research analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $19.75.

Amprius Technologies Stock Down 2.0%

The company has a 50 day moving average of $11.88 and a two-hundred day moving average of $11.07. The firm has a market cap of $2.34 billion, a P/E ratio of -52.72 and a beta of 3.04.

Amprius Technologies (NYSE:AMPX) last issued its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) EPS for the quarter, topping the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The firm had revenue of $25.23 million for the quarter, compared to analysts’ expectations of $22.91 million. Amprius Technologies has set its FY 2026 guidance at –0.060 EPS. Research analysts expect that Amprius Technologies, Inc. will post -0.45 earnings per share for the current fiscal year.

Insider Activity at Amprius Technologies

In other Amprius Technologies news, Director Steven Chu sold 155,565 shares of Amprius Technologies stock in a transaction that occurred on Thursday, March 12th. The shares were sold at an average price of $18.50, for a total value of $2,877,952.50. Following the transaction, the director owned 127,339 shares in the company, valued at approximately $2,355,771.50. The trade was a 54.99% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, Director Kang Sun sold 61,251 shares of the company’s stock in a transaction on Monday, February 23rd. The shares were sold at an average price of $10.16, for a total value of $622,310.16. Following the completion of the transaction, the director directly owned 1,342,400 shares in the company, valued at $13,638,784. This represents a 4.36% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 2,516,211 shares of company stock valued at $30,164,697 over the last ninety days. Insiders own 12.90% of the company’s stock.

Hedge Funds Weigh In On Amprius Technologies

Hedge funds and other institutional investors have recently modified their holdings of the stock. Bank of America Corp DE increased its stake in Amprius Technologies by 31.1% in the 4th quarter. Bank of America Corp DE now owns 12,890 shares of the company’s stock worth $36,000 after purchasing an additional 3,055 shares in the last quarter. AQR Capital Management LLC boosted its holdings in shares of Amprius Technologies by 86.7% in the first quarter. AQR Capital Management LLC now owns 77,764 shares of the company’s stock worth $208,000 after buying an additional 36,116 shares during the period. Millennium Management LLC increased its position in shares of Amprius Technologies by 94.5% in the first quarter. Millennium Management LLC now owns 1,396,013 shares of the company’s stock worth $3,741,000 after acquiring an additional 678,442 shares in the last quarter. Goldman Sachs Group Inc. raised its holdings in shares of Amprius Technologies by 128.6% during the first quarter. Goldman Sachs Group Inc. now owns 244,646 shares of the company’s stock valued at $656,000 after acquiring an additional 137,640 shares during the period. Finally, Rhumbline Advisers raised its holdings in shares of Amprius Technologies by 61.1% during the first quarter. Rhumbline Advisers now owns 15,690 shares of the company’s stock valued at $42,000 after acquiring an additional 5,951 shares during the period. Institutional investors and hedge funds own 5.04% of the company’s stock.

About Amprius Technologies

Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company’s batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.

At the core of Amprius’ product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.